The Role of Tumour Metabolism in Cisplatin Resistance
Cisplatin is a chemotherapy drug commonly used in cancer treatment. Tumour cells are more sensitive to cisplatin than normal cells. Cisplatin exerts an antitumour effect by interfering with DNA replication and transcription processes. However, the drug-resistance properties of tumour cells often cau...
Main Authors: | Lude Wang, Xiaoya Zhao, Jianfei Fu, Wenxia Xu, Jianlie Yuan |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2021-06-01
|
Series: | Frontiers in Molecular Biosciences |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fmolb.2021.691795/full |
Similar Items
-
DNA repair pathways and cisplatin resistance: an intimate relationship
by: Clarissa Ribeiro Reily Rocha, et al.
Published: (2018-09-01) -
Genomic Characterization of Cisplatin Response Uncovers Priming of Cisplatin-Induced Genes in a Resistant Cell Line
by: Hadar Golan Berman, et al.
Published: (2021-05-01) -
Advances of DNA Damage Repair and Cisplatin Resistance Mechanisms in Lung Cancer
by: Chunlan TANG, et al.
Published: (2011-12-01) -
Can Cisplatin Therapy Be Improved? Pathways That Can Be Targeted
by: Reem Ali, et al.
Published: (2022-06-01) -
Cisplatin as an Anti-Tumor Drug: Cellular Mechanisms of Activity, Drug Resistance and Induced Side Effects
by: Ana-Maria Florea, et al.
Published: (2011-03-01)